AdaptHealth Price to Book Ratio 2018-2025 | AHCO
Historical price to book ratio values for AdaptHealth (AHCO) over the last 10 years. The current price to book ratio for AdaptHealth as of July 01, 2025 is 0.81.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| AdaptHealth Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-01 | 9.40 | 0.81 | |
| 2025-03-31 | 10.84 | $11.66 | 0.93 |
| 2024-12-31 | 9.52 | $11.72 | 0.81 |
| 2024-09-30 | 11.23 | $11.33 | 0.99 |
| 2024-06-30 | 10.00 | $11.19 | 0.89 |
| 2024-03-31 | 11.51 | $11.04 | 1.04 |
| 2023-12-31 | 7.29 | $11.06 | 0.66 |
| 2023-09-30 | 9.10 | $12.89 | 0.71 |
| 2023-06-30 | 12.17 | $16.26 | 0.75 |
| 2023-03-31 | 12.43 | $16.16 | 0.77 |
| 2022-12-31 | 19.22 | $16.05 | 1.20 |
| 2022-09-30 | 18.78 | $16.03 | 1.17 |
| 2022-06-30 | 18.04 | $15.90 | 1.13 |
| 2022-03-31 | 16.03 | $15.80 | 1.01 |
| 2021-12-31 | 24.46 | $15.44 | 1.58 |
| 2021-09-30 | 23.29 | $15.09 | 1.54 |
| 2021-06-30 | 27.41 | $14.56 | 1.88 |
| 2021-03-31 | 36.76 | $13.85 | 2.65 |
| 2020-12-31 | 37.56 | $3.13 | 11.99 |
| 2020-09-30 | 21.81 | $4.97 | 4.39 |
| 2020-06-30 | 16.10 | $-0.11 | -140.24 |
| 2020-03-31 | 16.00 | $-0.40 | -40.16 |
| 2019-12-31 | 10.98 | $-0.53 | -20.83 |
| 2019-09-30 | 10.18 | $0.69 | 14.65 |
| 2019-06-30 | 10.13 | $0.70 | 14.54 |
| 2019-03-31 | 9.99 | $0.70 | 14.21 |
| 2018-12-31 | 9.83 | 0.00 | |
| 2018-09-30 | 9.72 | $0.69 | 14.12 |
| 2018-06-30 | 9.62 | $0.68 | 14.07 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.273B | $3.261B |
| AdaptHealth Corp. is a provider of home medical equipment primarily in the United States. It offers medical products for both rental and sale, with a focus on respiratory and/or mobility equipment, including CPAP sleep equipment, oxygen equipment, wheelchairs, walkers and hospital beds. AdaptHealth Corp., formerly known as DFB Healthcare Acquisitions Corp., is based in PLYMOUTH MEETING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |